Red Cat Revenue Jumps, But Still Bleeds Cash

Red Cat Holdings, Inc. ( RCAT ) has just reported somewhat mixed 4Q25 results; however, I still see the company on the right track. They posted a GAAP EPS of -$0.17, a figure that missed expectations byI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and ...